Compare TIGO & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TIGO | RVTY |
|---|---|---|
| Founded | 1990 | 1937 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 11.8B |
| IPO Year | 1997 | 1994 |
| Metric | TIGO | RVTY |
|---|---|---|
| Price | $73.37 | $97.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 15 |
| Target Price | $53.00 | ★ $113.00 |
| AVG Volume (30 Days) | 1.2M | ★ 1.4M |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | ★ 4.24% | 0.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $0.14 | $6.34 |
| Revenue Next Year | $17.84 | $5.10 |
| P/E Ratio | ★ $10.21 | $47.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $25.50 | $81.36 |
| 52 Week High | $72.23 | $120.39 |
| Indicator | TIGO | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 72.17 | 43.27 |
| Support Level | $46.19 | $88.56 |
| Resistance Level | N/A | $105.03 |
| Average True Range (ATR) | 2.32 | 3.37 |
| MACD | 0.34 | -0.13 |
| Stochastic Oscillator | 98.00 | 32.85 |
Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia (100% owned), Nicaragua (100%), Panama (100%), El Salvador (100%), Guatemala (100%), Paraguay (100%), Colombia (50%), and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm's wireless networks cover about 120 million people, serving 42 million customers. Its fixed-line networks reach 14 million homes, serving about 4 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm has agreed to acquire Telefonica's operations in Ecuador and Uruguay.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.